• Overview
  • Eligibility
  • More info
  • Locations

A Randomized Wait-list Controlled Trial on the Use of Emotional Freedom Techniques as an Intervention Strategy to Reduce Patient Reported Cognitive Complaints in Cancer Survivors on Behalf of the Belgian Society for Medical Oncology (BSMO)-Cancer Survivorship Taskforce (NCT02771028)

Universitair Ziekenhuis Brussel
AZ Klina Brasschaat
In this trial the investigators aim to establish whether Emotional Freedom Techniques (EFT) can reduce cognitive complaints in cancer survivors. All consenting patients aged 18 years or above, who have been diagnosed with a solid tumour of hematologic malignancy and who have completed or are in the late phase of a chemotherapy, radiotherapy, anti-hormonal or targeted therapy treatment, can participate in this trial. Patients should suffer from subjective cognitive complaints based on a score of 43 or more on the Cognitive Failure Questionnaire (CFQ). These patients will be randomly assigned to either the control or intervention group. Patients in the intervention group will be scheduled to receive an 8-week EFT intervention program. Other patients will be placed on an 8-week wait list after which patients will also start the EFT program.
  • Behavioral: Emotional Freedom Techniques
    Ages eligible for Study
    18 Years and older
    Genders eligible for Study
    Accepts Healthy Volunteers
    Inclusion Criteria:
    • Patients should have reached a minimum age of 18 years at the time of enrolment
    • Histologically confirmed diagnosis of a solid cancer or hematologic malignancy
    • Patients should have received chemo- or radiotherapy, targeted therapy of hormonal treatment before enrollment (active treatment with anti-hormonal therapy or brachytherapy is allowed)
    • Patients can be included in the latest phase of their chemotherapy, radiotherapy, anti-hormonal or targeted therapy treatment
    • Patients should have been treated with curative intent or have an expected life expectancy of at least 5 years
    • Patients must suffer from subjective cognitive complaints based on the Cognitive Failure Questionnaire (cut-off ≥ 43)
    • Patients should be able to adequately communicate in Dutch or French
    • Patients should present with a sufficient mental and physical functional status (according to investigator's judgment)
    Exclusion Criteria:
    • Patients who received a treatment with palliative intent
    • Patients showing signs of mental deterioration
    • Patients suffering from an organic brain syndrome
    • Patients who are alcohol or drug dependent
    • Patients with a major psychiatric or neurologic disorder that could potentially invalidate assessment; a prior or current diagnosis of a depressive, anxiety or adjustment disorder is allowed

    3 locations

    Belgium (3)
    • General Hospital Klina Brasschaat
      Brasschaat, Belgium, 2930
    • Brussels University Hospital
      Brussels, Belgium, 1090
    • General Hospital Groeninge
      Kortrijk, Belgium, 8500
    30 September, 2016
    10 September, 2017
    A girl giving information about available additional trials.

    FindMeCure helps you find, understand and join clinical trials from all over the world.

    There are more clinical trials for your condition!